A phase I clinical trial of topical peptide p144 TGF-beta1 inhibitor in healthy volunteers

被引：0
|
作者：
Sabada, Belen [1 ]
Ruiz, Belen [2 ]
Ruiz, Juan
Insa, Raul [3 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
[2] Hosp Univ Puerta de Hierro, Madrid, Spain
[3] ISDIN, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2009年 / 60卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB63 / AB63
页数：1
相关论文
共 50 条
  • [41] Single Doses of a Highly Selective Inhibitor of Phosphodiesterase 1 (Lenrispodun) in Healthy Volunteers: A Randomized Pharmaco-fMRI Clinical Trial
    Khalsa, Sahib
    Victor, Teresa
    Kuplicki, Rayus
    Yeh, Hung-Wen
    Vanover, Kimberly
    Paulus, Martin
    Davis, Robert
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 181 - 182
  • [42] Single doses of a highly selective inhibitor of phosphodiesterase 1 (lenrispodun) in healthy volunteers: a randomized pharmaco-fMRI clinical trial
    Sahib S. Khalsa
    Teresa A. Victor
    Rayus Kuplicki
    Hung-Wen Yeh
    Kimberly E. Vanover
    Martin P. Paulus
    Robert E. Davis
    Neuropsychopharmacology, 2022, 47 : 1844 - 1853
  • [43] Single doses of a highly selective inhibitor of phosphodiesterase 1 (lenrispodun) in healthy volunteers: a randomized pharmaco-fMRI clinical trial
    Khalsa, Sahib S.
    Victor, Teresa A.
    Kuplicki, Rayus
    Yeh, Hung-Wen
    Vanover, Kimberly E.
    Paulus, Martin P.
    Davis, Robert E.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (10) : 1844 - 1853
  • [44] Randomised clinical trial: the DPP-4 inhibitor, vildagliptin, inhibits gastric accommodation and increases glucagon-like peptide-1 plasma levels in healthy volunteers
    Rotondo, Alessandra
    Masuy, Imke
    Verbeure, Wout
    Biesiekierski, Jessica R.
    Deloose, Eveline
    Tack, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (08) : 997 - 1004
  • [45] Pharmacokinetic and Pharmacodynamic Profile of PEGylated Interferon Beta-1a in Healthy Volunteers: Results from Two Phase 1 Clinical Studies
    Hu, Xiao
    Subramanyam, Meena
    Lerner, Michaela
    Miller, Larisa
    Nestorov, Ivan
    Davar, Gudarz
    NEUROLOGY, 2009, 72 (11) : A316 - A317
  • [46] SKI2162, A NOVEL TRANSFORMING GROWTH FACTOR (TGF)-BETA TYPE I RECEPTOR KINASE (ALK5) INHIBITOR, ALLEVIATES PROFIBROTIC TGF-BETA1 RESPONSES IN FIBROBLASTS DERIVED FROM PEYRONIE'S PLAQUE
    Ryu, J. K.
    Piao, S.
    Choi, M. J.
    Tumurbaatar, M.
    Kim, W. J.
    Jin, H. R.
    Shin, S. H.
    Yim, G. N.
    Song, J. S.
    Kwon, M. H.
    Song, K. M.
    Suh, J. K.
    Song, Y. S.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 155 - 155
  • [47] CLINICAL PHARMACOLOGY PHASE-I OF CEFAZEDONE, A NEW CEPHALOSPORIN, IN HEALTHY VOLUNTEERS .1. TOLERANCE IN COMPARISON WITH CEFAZOLIN
    UNGETHUM, W
    LEOPOLD, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-2 (01): : 435 - 436
  • [48] A randomized Phase I bioequivalence clinical trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers
    Esseku, Fredrick
    Joshi, Anjali
    Oyegbile, Yemisi
    Edowhorhu, Grace
    Gbadero, Daniel
    Adeyeye, Moji
    ANTIVIRAL THERAPY, 2013, 18 (02) : 205 - 212
  • [49] Safety evaluation of Mikania glomerata and Mikania laevigata in healthy volunteers: A randomized, open label and multiple dose phase I clinical trial
    Bertol, Gustavo
    Cobre, Alexandre de Fatima
    Campos, Michel Leandro
    Pontarolo, Roberto
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 318
  • [50] Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial
    Li, Rui
    Zi, Ming-Jie
    Gou, Zhong-Ping
    Zhao, Yun-Li
    Zhang, Wan-Tong
    Lu, Fang
    Cao, Wei-Yi
    Zhao, Ying-Pan
    Li, Qing-Na
    Zhao, Yang
    Wang, Shu-Ge
    Gao, Hong-Yang
    Sun, Ming-Yue
    Luo, Xiao-Dong
    Xiong, Zhi-Li
    Gao, Rui
    PHYTOMEDICINE, 2019, 61
12345